Join/Watch the weekly
TMAU UP Podcasts

MEBO Private Facebook Group
to join : contact
maria.delatorre@meboresearch.org

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org

MEBO TMAU urine test

MEBO Research
TMAU Urine Test
United States only
PROGRAM IS PERMANENTLY SUSPENDED AS OF 2 MAY 2017

Click here for
REQUISITION FORM
Incomplete applications
will NOT be processed

SEE UPDATES HERE

1
test
$150 plus
shipping costs
2
tests
$250 plus
shipping costs

TWO PAYMENT PLAN OPTION
Send email to maria.delatorre@meboresearch.org to arrange, AFTER filling out Requisition Form, please.

Test analysis performed in batches of 20 or more

DATE: 2 MAY 2017
Currently on : PROGRAM IS TEMPORARILY SUSPENDED

Samples analyzed since June 2012 :
352
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Friday, February 20, 2015

Update: UK Grant-Funded TMAU therapeutic Research

a  PATIENT ADVOCACY International campaign to research SYSTEMIC BODY ODOR AND HALITOSIS

A 501(c)3 Public Charity, USA
A Not For Profit LTD Company, England and Wales


It's been sometime since we posted about the TMAU therapeutic research (scroll down on this link to see all posts). When the project was announced in late 2012 early 2013, the timing could not have been more perfect as it coincided with the World Premiere of the “The Boy who smells like Fish.” The video seems to be available on YouTube for viewing.

With a project of this size and nature, and out of respect for the grant and scientists, we have thought it was best to keep the communications line open, but not to be too intrusive on the progresses achieved.

We have had communications with the scientists during this time regarding the TMAU therapeutic research and the inclination is that the project is progressing very well. It is very much alive and well, and starting this year, the hope is to obtain additional large grant funding to further the project. MEBO remain positive and supportive in any way to the scientists, and hopeful that a clinical stage project will be more attractive for funding. The scientists are steadily progressing with TMAU above any others, so we are hopeful and believe that any outcomes derived from the project are beneficial in finding us an effective treatment, if not a cure. It is very encouraging to our community to see that this research is very much alive and well, and looking forward to a bright future.;

The project and grant are well documented at http://gtr.rcuk.ac.uk/project/772B5BB8-C185-455B-9AE2-C4BC7F8369DF.Below are some excerpts from this site:



Funded Value:
£358,124
Funded Period:
Aug 2013 - Aug 2015
Funder:
MRC
Project Status:
Active
Project Category:
Research Grant
Research Activity:
5.1 Pharmaceuticals(100%)

Planned Impact


The major beneficiaries of the therapy will be those who suffer from TMAU and their families and friends. Through her communications with patients, the PI is aware of the stigma, ridicule and other difficulties the patients face in their daily lives. The results from our pre-clinical study will provide a much-needed boost for those with TMAU. It will represent a pathway to a future therapy in humans. A therapy that can abolish body and breath odour will have a major impact on the quality of life of TMAU individuals, improving self-confidence and esteem, relationships and employment. A barrier to a normal life will be removed. The preclinical study runs for two years. With orphan drug designation and if fast track status is approved we anticipate a therapy to the clinic within five years…
Outcomes Impact: Patient group MEBO have access.


María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

5 comments:

Anonymous said...

How do they get a test group of people to be in the clinical trial when it starts. Will they look to our group first? Just wondering.......

Feb 21, 2015, 1:05:00 AM
Maria de la T., Founder and Executive Director, MEBO Research said...

I can't speak for the scientists performing this research, but in order for there to be the control needed for this study, I bet they will select the subjects who have tested positive for TMAU. The scientists will probably approach the physicians who perform the test and treatment in the UK, which many are involved with MEBO. But again, I can't speak for the scientists; this is just my speculation.

Feb 21, 2015, 7:16:00 PM
Maria de la T., Founder and Executive Director, MEBO Research said...

Some sufferers are becoming impatient and asking for the scientists who are carrying out this research to give an update now, only 1 1/2 years into this initial phase. Looking at this from the sufferer's point of view, 1 1/2 years is a long time to wait while experiencing symptoms and the psychosocial consequences. On the other hand, looking at this from the scientists' point of view, we've only just begun. It's very early in the process.

Scientists tend to be very closed lip while carrying on research. Mostly because they are in the process of gathering data to prove their theory. So, what if their research data proves their theory to be wrong, and then the theory is modified and tested, etc? If they had commented along the way, they would eventually be accused of making false claims, and rightfully so. They can't make any claims until they test their theories using the scientific method. It takes years before they can arrive at the point of being able to talk about it with some degree of certainty.

This is something we need to learn as sufferers waiting for research to be concluded. It is a great unknown; it is an exploration into a possibility, and it must be rigorously tested, modified, an re-tested until a level of certainty is obtained.

Feb 21, 2015, 7:22:00 PM
Anonymous said...

I hope they would consider people from other countries who have tested positive for TMAU. I have but it was done through Monnell and I don't know if they communicate or even know about the Trinzyme study. Anyway, I understand that we are still in the early stages of this. Thanks for posting the update Maria. It definitely gives hope and I know it makes me feel better about the future.

Feb 22, 2015, 11:09:00 AM
Anonymous said...

Any reason why they changed the funded period date on their website to January? I was looking forward to hearing some thing back this August but I guess I have to wait little longer.

Jul 30, 2015, 8:45:00 PM
Post a Comment